Search Results 4251-4260 of 25432 for oral

  1. Phase 2b Study of Investigational Products in Participants with Interstitial Lung Disease Secondary to Systemic Sclerosis - Mayo Clinic

    Oral corticosteroids equivalent to ≤ 10 mg/day prednisone if started at least ≤ 2 weeks prior to randomization. Inhaled and topical corticosteroids are ...

  2. A study to assess the effectiveness and safety of pacritinib in patients with VEXAS syndrome (PAXIS) - Mayo Clinic

    Oral JAK inhibitors: 14 days; Anti-IL-1 agents except for canakinumab: 14 days; Any other non-GC anti-inflammatory therapy (e.g., mycophenolate, azathioprine ...

  3. Phase 1 Study to Evaluate MEDI4736 in Subjects With Myelodysplastic Syndrome - Mayo Clinic

    ... oral hormonal contraceptive pills where inhibition of ovulation is not the primary mode of action [excluding Cerazette®/desogestrel which is considered ...

  4. Surgery - Doctors - Mayo Clinic

    Transoral robotic surgery, Parathyroidectomy, Reconstructive surgery, Oral surgery, Microvascular reconstruction, Trans...oral laser microsurgery, Facial ...

  5. Rheumatoid arthritis - Doctors and departments - Mayo Clinic

    Jonathan Fillmore, M.D., D.M.D.. Oral and Maxillofacial Surgeon. Rochester, MN. Areas of focus: Minimally invasive surgery, Trauma care, Joint replacement ...

  6. Head and neck cancers - Doctors and departments - Mayo Clinic

    Cancer Care at Mayo Clinic · Children's Center · Head and Neck Cancer Center · Neurosurgery · Oncology (Medical) · Oral and Maxillofacial Surgery · Otolaryngology ( ...

  7. Salivary gland tumors - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology ...

  8. Amaal J. Starling, M.D. - Doctors and Medical Staff - Mayo Clinic

    Third Place Award for Oral Presentation "CT Angiography and Perfusion Studies..."American Academy of Neurology. 2011. Manfred D. Muenter Award for ...

  9. A Study to Evaluate Dabrafenib and Trametinib With or Without Hydroxychloroquine in Advanced Melanoma - Mayo Clinic

    Patient must have discontinued any oral targeted therapy at least 2 weeks prior to randomization. Patients must not receive any other investigational ...

  10. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery ... Chang, M.D.. Otolaryngologist. Phoenix, AZ. Areas of focus: Transoral robotic ...